Patients suffering mucinous adenocarcinoma and receiving 5-FU show a diminished clinical response compared to those with nonmucinous tumors; this discrepancy likely results from a significant higher expression of TYMS gene encoding TS [100] (Figure 3). Here, TYMS is linked to mucinous adenocarcinoma.